U.S. Defense Health Agency Selects Amwell And Leidos To Power The Digital First Initiative For The U.S. Military Health System; Task Order Has 22-Month Period Of Performance With Total Value Up To $180M
Portfolio Pulse from Benzinga Newsdesk
The U.S. Defense Health Agency (DHA) has chosen Amwell and Leidos to power its Digital First initiative for the U.S. Military Health System. The task order has a 22-month period of performance with a total value of up to $180 million. The Amwell Converge™ platform will be used to deliver connected and seamless in-person, virtual, and automated care delivery.
October 19, 2023 | 8:27 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Amwell's Converge platform will be used by the U.S. Defense Health Agency, potentially increasing the company's revenues and visibility in the healthcare sector.
The selection of Amwell's platform by the U.S. Defense Health Agency is a significant endorsement of the company's technology and could lead to increased revenues and visibility. This could potentially have a positive impact on the company's stock price in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Leidos has been selected alongside Amwell by the U.S. Defense Health Agency for its Digital First initiative, which could lead to increased revenues and visibility for the company.
Leidos' selection by the U.S. Defense Health Agency is a significant endorsement and could lead to increased revenues and visibility. This could potentially have a positive impact on the company's stock price in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80